Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells

Molecular and Cellular Endocrinology

Volumn 294, Issue 1-2, 2008, Pages 81-91

  Soto Guzman, Adriana ^a   Robledo, Teresa ^a   Lopez Perez, Mario ^a   Salazar, Eduardo Perez ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

AP 1; Breast cancer; ERK1 2; MCF 7; MDA MB 231; Oleic acid

Indexed keywords

DNA; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 40; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OLEIC ACID; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, NEOPLASM; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OLEIC ACID; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, G-PROTEIN-COUPLED; SRC-FAMILY KINASES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 53649083414     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.08.003     Document Type: Article

References (85)

1. Acosta J.J., Munoz R.M., Gonzalez L., Subtil-Rodriguez A., Dominguez-Caceres M.A., Garcia-Martinez J.M., Calcabrini A., Lazaro-Trueba I., and Martin-Perez J. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Mol. Endocrinol. 17 (2003) 2268-2282
2. Alexander L.D., Alagarsamy S., and Douglas J.G. Cyclic stretch-induced cPLA2 mediates ERK 1/2 signaling in rabbit proximal tubule cells. Kidney Int. 65 (2004) 551-563
3. Alexander L.D., Ding Y., Alagarsamy S., Cui X.L., and Douglas J.G. Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor. Kidney Int. 69 (2006) 1823-1832
4. Ali S., and Coombes R.C. Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2 (2002) 101-112
5. Angel P., Imagawa M., Chiu R., Stein B., Imbra R.J., Rahmsdorf H.J., Jonat C., Herrlich P., and Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49 (1987) 729-739
6. Angel P., and Karin M. The role of Jun Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072 (1991) 129-157
7. Bahassi el M., Karyala S., Tomlinson C.R., Sartor M.A., Medvedovic M., and Hennigan R.F. Critical regulation of genes for tumor cell migration by AP-1. Clin. Exp. Metastasis 21 (2004) 293-304
8. Benbow U., and Brinckerhoff C.E. The AP-1 site and MMP gene regulation: what is all the fuss about?. Matrix Biol. 15 (1997) 519-526
9. Biscardi J.S., Maa M.C., Tice D.A., Cox M.E., Leu T.H., and Parsons S.J. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274 (1999) 8335-8343
10. Biscardi J.S., Tice D.A., and Parsons S.J. c-Src, receptor tyrosine kinases, and human cancer. Adv. Cancer Res. 76 (1999) 61-119
11. Boyd N.F., Stone J., Vogt K.N., Connelly B.S., Martin L.J., and Minkin S. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br. J. Cancer 89 (2003) 1672-1685
12. Briscoe C.P., Tadayyon M., Andrews J.L., Benson W.G., Chambers J.K., Eilert M.M., Ellis C., Elshourbagy N.A., Goetz A.S., Minnick D.T., Murdock P.R., Sauls Jr. H.R., Shabon U., Spinage L.D., Strum J.C., Szekeres P.G., Tan K.B., Way J.M., Ignar D.M., Wilson S., and Muir A.I. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278 (2003) 11303-11311
13. Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., Muir A.I., Wigglesworth M.J., Kinghorn I., Fraser N.J., Pike N.B., Strum J.C., Steplewski K.M., Murdock P.R., Holder J.C., Marshall F.H., Szekeres P.G., Wilson S., Ignar D.M., Foord S.M., Wise A., and Dowell S.J. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278 (2003) 11312-11319
14. Danielian P.S., White R., Lees J.A., and Parker M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11 (1992) 1025-1033
15. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
16. Eferl R., and Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3 (2003) 859-868
17. Egan C., Pang A., Durda D., Cheng H.C., Wang J.H., and Fujita D.J. Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530. Oncogene 18 (1999) 1227-1237
18. Eguchi S., Numaguchi K., Iwasaki H., Matsumoto T., Yamakawa T., Utsunomiya H., Motley E.D., Kawakatsu H., Owada K.M., Hirata Y., Marumo F., and Inagami T. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 273 (1998) 8890-8896
19. Fay M.P., Freedman L.S., Clifford C.K., and Midthune D.N. Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res. 57 (1997) 3979-3988
20. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53 Suppl. 1 (2004) S43-50
21. Filardo E.J., Quinn J.A., Bland K.I., and Frackelton Jr. A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14 (2000) 1649-1660
22. Fischer O.M., Hart S., Gschwind A., and Ullrich A. EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 31 (2003) 1203-1208
23. Font de Mora J., and Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell. Biol. 20 (2000) 5041-5047
24. Grobelny D., Poncz L., and Galardy R.E. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry 31 (1992) 7152-7154
25. Guy C.T., Muthuswamy S.K., Cardiff R.D., Soriano P., and Muller W.J. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev. 8 (1994) 23-32
26. Hancock C.N., Macias A., Lee E.K., Yu S.Y., Mackerell Jr. A.D., and Shapiro P. Identification of novel extracellular signal-regulated kinase docking domain inhibitors. J. Med. Chem. 48 (2005) 4586-4595
27. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., and Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271 (1996) 695-701
28. Hardy S., Langelier Y., and Prentki M. Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res. 60 (2000) 6353-6358
29. Hardy S., St-Onge G.G., Joly E., Langelier Y., and Prentki M. Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J. Biol. Chem. 280 (2005) 13285-13291
30. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., Sugimoto Y., Miyazaki S., and Tsujimoto G. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 11 (2005) 90-94
31. Itoh Y., Kawamata Y., Harada M., Kobayashi M., Fujii R., Fukusumi S., Ogi K., Hosoya M., Tanaka Y., Uejima H., Tanaka H., Maruyama M., Satoh R., Okubo S., Kizawa H., Komatsu H., Matsumura F., Noguchi Y., Shinohara T., Hinuma S., Fujisawa Y., and Fujino M. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422 (2003) 173-176
32. Jacobs C., and Rubsamen H. Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas. Cancer Res. 43 (1983) 1696-1702
33. Jorissen R.N., Walker F., Pouliot N., Garrett T.P., Ward C.W., and Burgess A.W. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 284 (2003) 31-53
34. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., and Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 (1995) 1491-1494
35. Kumar V., Green S., Stack G., Berry M., Jin J.R., and Chambon P. Functional domains of the human estrogen receptor. Cell 51 (1987) 941-951
36. Lahmann P.H., Hoffmann K., Allen N., van Gils C.H., Khaw K.T., Tehard B., Berrino F., Tjonneland A., Bigaard J., Olsen A., Overvad K., Clavel-Chapelon F., Nagel G., Boeing H., Trichopoulos D., Economou G., Bellos G., Palli D., Tumino R., Panico S., Sacerdote C., Krogh V., Peeters P.H., Bueno-de-Mesquita H.B., Lund E., Ardanaz E., Amiano P., Pera G., Quiros J.R., Martinez C., Tormo M.J., Wirfalt E., Berglund G., Hallmans G., Key T.J., Reeves G., Bingham S., Norat T., Biessy C., Kaaks R., and Riboli E. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int. J. Cancer 111 (2004) 762-771
37. Le Poul E., Loison C., Struyf S., Springael J.Y., Lannoy V., Decobecq M.E., Brezillon S., Dupriez V., Vassart G., Van Damme J., Parmentier M., and Detheux M. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278 (2003) 25481-25489
38. Lee A.V., Cui X., and Oesterreich S. Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer. Clin. Cancer Res. 7 (2001) 4429s-4435s 4411s-4412s discussion
39. Lee M.M., and Lin S.S. Dietary fat and breast cancer. Annu. Rev. Nutr. 20 (2000) 221-248
40. Lee W., Mitchell P., and Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49 (1987) 741-752
41. Levitzki A., and Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 267 (1995) 1782-1788
42. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., Bourguignon L., and Hung M.C. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 3 (2001) 802-808
43. Louet J.F., Chatelain F., Decaux J.F., Park E.A., Kohl C., Pineau T., Girard J., and Pegorier J.P. Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway. Biochem. J. 354 (2001) 189-197
44. Lu G., Morinelli T.A., Meier K.E., Rosenzweig S.A., and Egan B.M. Oleic acid-induced mitogenic signaling in vascular smooth muscle cells A role for protein kinase C. Circ. Res. 79 (1996) 611-618
45. Luttrell D.K., and Luttrell L.M. Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene 23 (2004) 7969-7978
46. Luttrell L.M., Della Rocca G.J., van Biesen T., Luttrell D.K., and Lefkowitz R.J. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 272 (1997) 4637-4644
47. Maziere C., Conte M.A., Degonville J., Ali D., and Maziere J.C. Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem. Biophys. Res. Commun. 265 (1999) 116-122
48. McArthur M.J., Atshaves B.P., Frolov A., Foxworth W.D., Kier A.B., and Schroeder F. Cellular uptake and intracellular trafficking of long chain fatty acids. J. Lipid Res. 40 (1999) 1371-1383
49. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20 (1999) 321-344
50. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer 41 (2005) 2449-2461
51. Milde-Langosch K., Janke S., Wagner I., Schroder C., Streichert T., Bamberger A.M., Janicke F., and Loning T. Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility. Breast Cancer Res. Treat. 107 (2007) 337-347
52. Milde-Langosch K., Roder H., Andritzky B., Aslan B., Hemminger G., Brinkmann A., Bamberger C.M., Loning T., and Bamberger A.M. The role of the AP-1 transcription factors c-Fos, FosB Fra-1 and Fra-2 in the invasion process of mammary carcinomas. Breast Cancer Res. Treat. 86 (2004) 139-152
53. Moss J., and Vaughan M. ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins. Adv. Enzymol. Relat. Areas Mol. Biol. 61 (1988) 303-379
54. Nicholson R.I., McClelland R.A., Robertson J.F., and Gee J.M. Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer. Endocr. Relat. Cancer 6 (1999) 373-387
55. Ozanne B.W., Spence H.J., McGarry L.C., and Hennigan R.F. Transcription factors control invasion: AP-1 the first among equals. Oncogene 26 (2007) 1-10
56. Pai R., Soreghan B., Szabo I.L., Pavelka M., Baatar D., and Tarnawski A.S. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 8 (2002) 289-293
57. Paine E., Palmantier R., Akiyama S.K., Olden K., and Roberts J.D. Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway. J. Biol. Chem. 275 (2000) 11284-11290
58. Parsons J.T., and Parsons S.J. Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr. Opin. Cell Biol. 9 (1997) 187-192
59. Payne D.M., Rossomando A.J., Martino P., Erickson A.K., Her J.H., Shabanowitz J., Hunt D.F., Weber M.J., and Sturgill T.W. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10 (1991) 885-892
60. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402 (1999) 884-888
61. Rao G.N., Baas A.S., Glasgow W.C., Eling T.E., Runge M.S., and Alexander R.W. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem. 269 (1994) 32586-32591
62. Rinehart-Kim J., Johnston M., Birrer M., and Bos T. Alterations in the gene expression profile of MCF-7 breast tumor cells in response to c-Jun. Int. J. Cancer 88 (2000) 180-190
63. Robledo T., Arriaga-Pizano L., Lopez-Perez M., and Salazar E.P. Type IV collagen induces STAT5 activation in MCF7 human breast cancer cells. Matrix Biol. 24 (2005) 469-477
64. Roche E., Buteau J., Aniento I., Reig J.A., Soria B., and Prentki M. Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. Diabetes 48 (1999) 2007-2014
65. Rose D.P. Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am. J. Clin. Nutr. 66 (1997) 1513S-1522S
66. Rosen N., Bolen J.B., Schwartz A.M., Cohen P., DeSeau V., and Israel M.A. Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J. Biol. Chem. 261 (1986) 13754-13759
67. Santen R.J., Song R.X., McPherson R., Kumar R., Adam L., Jeng M.H., and Yue W. The role of mitogen-activated protein (MAP) kinase in breast cancer. J. Steroid Biochem. Mol. Biol 80 (2002) 239-256
68. Sauer L.A., Dauchy R.T., and Blask D.E. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids. Cancer Res. 60 (2000) 5289-5295
69. Schreiber E., Matthias P., Muller M.M., and Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17 (1989) 6419
70. Schwartzberg P.L. The many faces of Src: multiple functions of a prototypical tyrosine kinase. Oncogene 17 (1998) 1463-1468
71. Seger R., and Krebs E.G. The MAPK signaling cascade. FASEB J. 9 (1995) 726-735
72. Shah B.H., and Catt K.J. A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol. Sci. 24 (2003) 239-244
73. Shaulian E., and Karin M. AP-1 in cell proliferation and survival. Oncogene 20 (2001) 2390-2400
74. Sinnett-Smith J., Santiskulvong C., Duque J., and Rozengurt E. [D-Arg(1),D-Trp(5,7,9) Leu(11)]Substance P inhibits bombesin-induced mitogenic signal transduction mediated by both G(q) and G(12) in Swiss 3T3cells. J. Biol. Chem. 275 (2000) 30644-30652
75. Smith L.M., Wise S.C., Hendricks D.T., Sabichi A.L., Bos T., Reddy P., Brown P.H., and Birrer M.J. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18 (1999) 6063-6070
76. Soule H.D., Maloney T.M., Wolman S.R., Peterson Jr. W.D., Brenz R., McGrath C.M., Russo J., Pauley R.J., Jones R.F., and Brooks S.C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50 (1990) 6075-6086
77. Stover D.R., Becker M., Liebetanz J., and Lydon N.B. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha. J. Biol. Chem. 270 (1995) 15591-15597
78. Traxler P., Bold G., Frei J., Lang M., Lydon N., Mett H., Buchdunger E., Meyer T., Mueller M., and Furet P. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3 4-d]pyrimidines. J. Med. Chem. 40 (1997) 3601-3616
79. Tulchinsky E. Fos family members: regulation, structure and role in oncogenic transformation. Histol. Histopathol. 15 (2000) 921-928
80. Vacaresse N., Lajoie-Mazenc I., Auge N., Suc I., Frisach M.F., Salvayre R., and Negre-Salvayre A. Activation of epithelial growth factor receptor pathway by unsaturated fatty acids. Circ. Res. 85 (1999) 892-899
81. van Landeghem A.A., Poortman J., Nabuurs M., and Thijssen J.H. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res. 45 (1985) 2900-2906
82. Wetzker R., and Bohmer F.D. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat. Rev. Mol. Cell Biol. 4 (2003) 651-657
83. Xiong Y., Miyamoto N., Shibata K., Valasek M.A., Motoike T., Kedzierski R.M., and Yanagisawa M. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1045-1050
84. Yonezawa T., Katoh K., and Obara Y. Existence of GPR40 functioning in a human breast cancer cell line MCF-7. Biochem. Biophys. Res. Commun. 314 (2004) 805-809
85. Zoumpourlis V., Papassava P., Linardopoulos S., Gillespie D., Balmain A., and Pintzas A. High levels of phosphorylated c-Jun, Fra-1 Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Oncogene 19 (2000) 4011-4021